A
Artelo Biosciences D
D
ARTL
7.09000
USD
-0.94
(-11.71%)
Market Closed
Volume
14,857
EPS
-10
Div Yield
-
P/E
-0
Market Cap
15,064,633
Title: Artelo Biosciences Inc
Sector: Healthcare
Industry: Biotechnology
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors& neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.